Abstract
The extent of hematologic effects of the new continuous flow left ventricular assist devices (CF-LVAD) has not been studied. Recent clinical studies have demonstrated that hemolysis and thrombosis are not common during CF-LVAD support, however, the incidence of bleeding remains a concern. The rate of postoperative bleeding is similar to that of the prior generation pulsatile LVAD, but gastrointestinal bleeding due to angiodysplasia and arteriovenous malformations is more common and appears to be related to the blood flow rheology of these devices. New evidence suggests that acquired von Willebrand’s disease develops in some patients due to the reduction in high molecular weight (HMW) multimers of von Willebrand’s factor (vWF). Similar to acquired von Willebrand’s disease seen in patients with aortic stenosis, the shear stress of the CF-LVAD may cause proteolysis of the HMW multimers of vWF. In addition to acquired von Willebrand’s disease, there is activation of the fibrinolytic system and a loss of platelet numbers and function during CF-LVAD support. The hematologic responses during CF-LVAD support are constantly changing, and antiplatelet therapy may need to be adjusted accordingly. Considerable research is needed to better define the complex hematologic effects during CF-LVAD support. Screening of patients for angiodysplasia and von Willebrand’s disease before CF-LVAD implant may allow for effective preemptive treatment. Because bleeding causes significant morbidity for this population, more effective treatment strategies need to be developed.
Similar content being viewed by others
References
Lahpor, J. R. (2009). State of the art: implantable ventricular assist devices. Current Opinion in Organ Transplantation, 14(5), 554–559.
Pagani, F. D. (2008). Continuous-flow rotary left ventricular assist devices with “3rd generation” design. Seminars in Thoracic and Cardiovascular Surgery, 20(3), 255–263.
Slaughter, M. S., Pagani, F. D., Rogers, J. G., Miller, L. W., Sun, B., Russell, S. D., et al. (2010). Clinical management of continuous-flow left ventricular assist devices in advanced heart failure. The Journal of Heart and Lung Transplantation, 29, S1–S39.
Pagani, F. D., Miller, L. W., Russell, S. D., Aaronson, K. D., John, R., Boyle, A. J., et al. (2009). Extended mechanical circulatory support with a continuous-flow rotary left ventricular assist device. Journal of the American College of Cardiology, 54(4), 312–321.
Goldstein, D. J. (2003). Worldwide experience with the MicroMed DeBakey Ventricular Assist Device as a bridge to transplantation. Circulation, 108(Suppl 1), II272–II277.
Miller, L. W., Pagani, F. D., Russell, S. D., John, R., Boyle, A. J., Aaronson, K. D., et al. (2007). Use of a continuous-flow device in patients awaiting heart transplantation. The New England Journal of Medicine, 357(9), 885–896.
Geisen, U., Heilmann, C., Beyersdorf, F., Benk, C., Berchtold-Herz, M., Schlensak, C., et al. (2008). Non-surgical bleeding in patients with ventricular assist devices could be explained by acquired von Willebrand disease. European Journal of Cardiothoracic Surgery, 33(4), 679–684.
Letsou, G. V., Shah, N., Gregoric, I. D., Myers, T. J., Delgado, R., & Frazier, O. H. (2005). Gastrointestinal bleeding from arteriovenous malformations in patients supported by the Jarvik 2000 axial-flow left ventricular assist device. The Journal of Heart and Lung Transplantation, 24(1), 105–109.
Pennington, D. G., McBride, L. R., Kanter, K. R., Miller, L. W., Ruzevich, S. A., Naunheim, K., et al. (1989). Bridging to heart transplantation with circulatory support devices. The Journal of Heart Transplantation, 8(2), 116–123.
Frazier, O. H., Rose, E. A., Macmanus, Q., Burton, N. A., Lefrak, E. A., Poirier, V. L., et al. (1992). Multicenter clinical evaluation of the HeartMate 1000 IP left ventricular assist device. The Annals of Thoracic Surgery, 53(6), 1080–1090.
Guyton, R. A., Schonberger, J. P., Everts, P. A., Jett, G. K., Gray, L. A., Jr., Gielchinsky, I., et al. (1993). Postcardiotomy shock: clinical evaluation of the BVS 5000 Biventricular Support System. The Annals of Thoracic Surgery, 56(2), 346–356.
Slaughter, M. S., Rogers, J. G., Milano, C. A., Russell, S. D., Conte, J. V., Feldman, D., et al. (2009). Advanced heart failure treated with continuous-flow left ventricular assist device. The New England Journal of Medicine, 361(23), 2241–2251.
Slaughter, M. S., Sobieski, M. A., Gallagher, C., Graham, J., Brandise, J., & Stein, R. (2008). Fibrinolytic activation during long-term support with the HeartMate II left ventricular assist device. ASAIO Journal, 54(1), 115–119.
John, R., Panch, S., Hrabe, J., Wei, P., Solovey, A., Joyce, L., et al. (2009). Activation of endothelial and coagulation systems in left ventricular assist device recipients. The Annals of Thoracic Surgery, 88, 1171–1179.
Livingston, E. R., Fisher, C. A., Bibidakis, E. J., Pathak, A. S., Todd, B. A., Furukawa, S., et al. (1996). Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation, 94, II227–II234.
Spanier, T., Oz, M., Levin, H., Weinberg, A., Stamatis, K., Stern, D., et al. (1996). Activation of coagulation and fibrinolytic pathways in patients with left ventricular assist devices. The Journal of Thoracic and Cardiovascular Surgery, 112, 1090–1097.
Thoennissen, N. H., Schneider, M., Allroggen, A., Ritter, M., Dittrich, R., Schmid, C., et al. (2005). High level of cerebral microembolization in patients supported with the DeBakey left ventricular assist device. The Journal of Thoracic and Cardiovascular Surgery, 130(4), 1159–1166.
Westaby, S., Banning, A. P., Jarvik, R., Frazier, O. H., Pigott, D. W., Jin, X. Y., et al. (2000). First permanent implant of the Jarvik 2000 Heart. Lancet, 356(9233), 900–903.
Hayes, H., Dembo, L., Larbalestier, R., & O’Driscoll, G. (2008). Successful treatment of ventricular assist device associated ventricular thrombus with systemic tenecteplase. Heart, Lung & Circulation, 17(3), 253–255.
Delgado, R., 3rd, Frazier, O. H., Myers, T. J., Gregoric, I. D., Robertson, K., & Shah, N. A. (2005). Direct thrombolytic therapy for intraventricular thrombosis in patients with the Jarvik 2000 left ventricular assist device. The Journal of Heart and Lung Transplantation, 24(2), 231–233.
Westaby, S., Banning, A. P., Saito, S., Pigott, D. W., Jin, X. Y., Catarino, P. A., et al. (2002). Circulatory support for long-term treatment of heart failure: experience with an intraventricular continuous flow pump. Circulation, 105(22), 2588–2591.
Crow, S., John, R., Boyle, A., Shumway, S., Liao, K., Colvin-Adams, M., et al. (2009). Gastrointestinal bleeding rates in recipients of nonpulsatile and pulsatile left ventricular assist devices. The Journal of Thoracic and Cardiovascular Surgery, 137(1), 208–215.
Mason, N. O., Reid, B. B., Marmstan, G., Jones, J., Stoker, S., Budge, D., et al. (2010). Characterization of gastrointestinal bleeding in Heartmate II left ventricular assist device patients. The Journal of Heart and Lung Transplantation, 29(2S), S9.
Wang, I. W., Guthrie, T., Ewald, G. A., Geltman, E. M., Joseph, S., & Moazami, N. (2010). Gastrointestinal bleeding complications in continuous flow LVAD patients—is it device specific? The Journal of Heart and Lung Transplantation, 29(2S), S8.
Siddiqui, M. A., Slaughter, M. S., & Silva, R. G. (2009). Gastrointestinal complications in patients supported with ventricular assist devices. Gastroenterology, 136(5), A213–A214.
Boyle, A. J., Russell, S. D., Teuteberg, J. J., Slaughter, M. S., Moazami, N., Pagani, F. D., et al. (2009). Low thromboembolism and pump thrombosis with the HeartMate II left ventricular assist device: analysis of outpatient anti-coagulation. The Journal of Heart and Lung Transplantation, 28(9), 881–887.
Heyde, E. C. (1958). Gastrointestinal bleeding in aortic stenosis [letter]. The New England Journal of Medicine, 259, 196.
Warkentin, T. E., Moore, J. C., & Morgan, D. G. (1992). Aortic stenosis and bleeding gastrointestinal angiodysplasia: is acquired von Willebrand’s disease the link? Lancet, 340(8810), 35–37.
Cappell, M. S., & Lebwohl, O. (1986). Cessation of recurrent bleeding from gastrointestinal angiodysplasias after aortic valve replacement. Annals of Internal Medicine, 105(1), 54–57.
Sucker, C. (2007). The Heyde syndrome: proposal for a unifying concept explaining the association of aortic valve stenosis, gastrointestinal angiodysplasia and bleeding. International Journal of Cardiology, 115(1), 77–78.
Williams, R. C., Jr. (2003). Aortic stenosis, von Willebrand factor, and bleeding. The New England Journal of Medicine, 349(18), 1773–1774. author reply 1773–4.
Pareti, F. I., Lattuada, A., Bressi, C., Zanobini, M., Sala, A., Steffan, A., et al. (2000). Proteolysis of von Willebrand factor and shear stress-induced platelet aggregation in patients with aortic valve stenosis. Circulation, 102(11), 1290–1295.
Yoshida, K., Tobe, S., Kawata, M., & Yamaguchi, M. (2006). Acquired and reversible von Willebrand disease with high shear stress aortic valve stenosis. The Annals of Thoracic Surgery, 81(2), 490–494.
Batur, P., Stewart, W. J., & Isaacson, J. H. (2003). Increased prevalence of aortic stenosis in patients with arteriovenous malformations of the gastrointestinal tract in Heyde syndrome. Archives of Internal Medicine, 163(15), 1821–1824.
Morishima, A., Marui, A., Shimamoto, T., Saji, Y., Tambara, K., Nishina, T., et al. (2007). Successful aortic valve replacement for Heyde syndrome with confirmed hematologic recovery. The Annals of Thoracic Surgery, 83(1), 287–288.
Malehsa, D., Meyer, A. L., Bara, C., & Struber, M. (2009). Acquired von Willebrand syndrome after exchange of the HeartMate XVE to the HeartMate II ventricular assist device. European Journal of Cardiothoracic Surgery, 35(6), 1091–1093.
Klovaite, J., Gustafsson, F., Mortensen, S. A., Sander, K., & Nielsen, L. B. (2009). Severely impaired von Willebrand factor-dependent platelet aggregation in patients with a continuous-flow left ventricular assist device (HeartMate II). Journal of the American College of Cardiology, 53(23), 2162–2167.
John, R., Kamdar, F., Liao, K., Colvin-Adams, M., Miller, L., Joyce, L., et al. (2008). Low thromboembolic risk for patients with the Heartmate II left ventricular assist device. The Journal of Thoracic and Cardiovascular Surgery, 136(5), 1318–1323.
Slaughter, M. S., Naka, Y., John, R., Boyle, A. J., Conte, J. V., Russell, S. D., et al. (2009). Postoperative heparin is not required in transitioning patients with HeartMate II LVAD to long term warfarin therapy. The Journal of Heart and Lung Transplantation, 28(2S), S153.
Holman, W. L., Teitel, E. R., & Itescu, S. (2006). Biologic barriers to mechanical circulatory support. In O. H. Frazier & J. K. Kirklin (Eds.), ISHLT monograft series (pp. 9–32). New York: Elsevier.
Bonaros, N., Mueller, M. R., Salat, A., Schima, H., Roethy, W., Kocher, A. A., et al. (2004). Extensive coagulation monitoring in patients after implantation of the MicroMed Debakey continuous flow axial pump. ASAIO Journal, 50(5), 424–431.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Slaughter, M.S. Hematologic Effects of Continuous Flow Left Ventricular Assist Devices. J. of Cardiovasc. Trans. Res. 3, 618–624 (2010). https://doi.org/10.1007/s12265-010-9222-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12265-010-9222-6